To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
HIV/AIDS: Drugs
Tuesday 22nd September 2026

Asked by: Lord Doyle (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the draft guidance from NICE which states that it cannot recommend the use of lenacapavir for reducing the risk of HIV; and what impact this will have on their target to end new HIV transmissions in England by 2030.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

No assessment has been made. The National Institute for Health and Care Excellence (NICE) develops its guidance independently based on the evidence of clinical and cost effectiveness. NICE has not yet published final guidance on lenacapavir and is currently consulting on its draft guidance.